Werner Kroll
Net Worth

Last updated:

What is Werner Kroll net worth?

The estimated net worth of Dr. Werner Kroll is at least $11,713,709 as of 28 Jul 2024. He owns shares worth $217,143 as insider, has earned $4,615,846 from insider trading and has received compensation worth at least $6,880,720 in QuidelOrtho Corporation.

What is the salary of Werner Kroll?

Dr. Werner Kroll salary is $860,090 per year as Senior Vice President of R&D in QuidelOrtho Corporation.

How old is Werner Kroll?

Dr. Werner Kroll is 68 years old, born in 1957.

What stocks does Werner Kroll currently own?

As insider, Dr. Werner Kroll owns shares in one company:

Company Title Shares Price per share Total value
QuidelOrtho Corporation (QDEL) Senior Vice President of R&D 8,119 $26.75 $217,143

What does QuidelOrtho Corporation do?

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Werner Kroll insider trading

QuidelOrtho Corporation

Dr. Werner Kroll has made 11 insider trades between 2017-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 68,152 units of QDEL stock on 22 May 2020. As of 28 Jul 2024 he still owns at least 8,119 units of QDEL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 1,170 N/A N/A
Option
Restricted Stock Units 3,811 N/A N/A
Option
Restricted Stock Units 1,313 N/A N/A
Option
Restricted Stock Units 3,628 N/A N/A
Option
Restricted Stock Units 3,547 N/A N/A
Option
Restricted Stock Units 1,170 N/A N/A
Option
Restricted Stock Units 981 N/A N/A
Option
Restricted Stock Units (Premium) 1,646 N/A N/A
Option
Restricted Stock Units 4,268 N/A N/A
Option
Restricted Stock Units 1,312 N/A N/A
Option
Restricted Stock Units 3,547 N/A N/A
Option
Restricted Stock Units 1,170 N/A N/A
Option
Restricted Stock Units 981 N/A N/A
Option
Restricted Stock Units (Premium) 420 N/A N/A
Option
Restricted Stock Units 4,268 N/A N/A
Option
Restricted Stock Units 1,312 N/A N/A
Option
Restricted Stock Units 4,606 N/A N/A
Option
Restricted Stock Units 982 N/A N/A
Option
Common Stock 982 N/A N/A
Option
Common Stock 4,376 N/A N/A
Option
Restricted Stock Units 4,376 N/A N/A
Sale
Common Stock 5,283 $173.72 $917,736
Sale
Common Stock 4,835 $165.48 $800,076
Sale
Common Stock 4,835 $165.48 $800,076
Option
Non-Qualified Stock Options 5,888 $33.75 $198,691
Option
Non-Qualified Stock OPtions 3,926 $59.12 $232,105
Sale
Common Stock 12,784 $164.11 $2,097,957
Option
Non-Qualified Stock Options 5,888 $33.75 $198,691
Option
Common Stock 12,784 $43.62 $557,574
Option
Common Stock 12,784 $5.27 $67,372
Option
Restricted Stock Units (Converted) 3,519 N/A N/A
Option
Restricted Stock Units 7,172 N/A N/A
Option
Restricted Stock Units 4,268 N/A N/A
Option
Restricted Stock Units 2,970 N/A N/A
Sale
Common Stock 2,072 N/A N/A
Option
Restricted Stock Units 2,944 N/A N/A
Option
Common Stock 4,376 N/A N/A
Option
Restricted Stock Units 4,376 N/A N/A
Option
Common Stock 68,152 $26.58 $1,811,139
Option
Common Stock 68,152 N/A N/A
Option
Non-Qualified Stock Options 32,960 N/A N/A
Sale
Common Stock 68,152 N/A N/A
Sale
Common Stock 16,331 N/A N/A
Option
Common Stock 6,620 N/A N/A
Option
Non-Qualified Stock Options 6,620 N/A N/A
Sale
Common Stock 2,500 N/A N/A
Option
Non-Qualified Stock Option 16,358 N/A N/A
Sale
Common Stock 7,100 N/A N/A
Option
Common Stock 16,358 N/A N/A
Option
Non-Qualified Stock Option 13,536 N/A N/A
Option
Common Stock 13,536 N/A N/A
Sale
Common Stock 12,298 N/A N/A
Option
Non-Qualified Stock Option 7,565 N/A N/A
Sale
Common Stock 7,565 N/A N/A
Option
Common Stock 7,565 N/A N/A

QuidelOrtho key executives

QuidelOrtho Corporation executives and other stock owners filed with the SEC: